HEALTH

Innovative BioDefense inks deal with Picketts Health to distribute Zylast antimicrobial product globally

BY Michael Johnsen

LAKE FOREST, Calif. — Innovative BioDefense, manufacturer of the Zylast line of broad-spectrum, persistent antimicrobial products, on Tuesday announced an exclusive relationship with Australian-based Picketts Health to provide a modification of their proprietary lotion and antiseptic sanitizer for use in Picketts Health’s patented Orbel hand sanitizer applicator.  

“We are pleased Picketts Health has taken an important step towards solving the issue of compliance with the introduction of the Orbel,” stated Colette Cozean, Innovative BioDefense CEO. “Their choice in bringing Zylast in as the formulary shows their commitment to providing the premier antimicrobial solution.”  

The first markets Picketts Health plans to target are the United Kingdom, South Africa, Australia and China.  Zylast is protected by trademarks and patents pending in many countries worldwide.

The Orbel was designed to increase hand-hygiene compliance and help prevent the spread of bacteria, viruses and infections. Portable, with single-handed activation of a regulated dose, the Orbel’s multi-directional balls evenly facilitate distribution to all parts of the hands for increased protection.

Zylast has shown to kill 99.99% of most disease-causing germs in 15 seconds and is persistent for six hours, the company stated. 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Infirst Healthcare to promote pediatric cough-cold brand Dr. Cocoa in U.S. market

BY Michael Johnsen

LONDON — Infirst Healthcare earlier this month secured the rights to market Dr. Cocoa, an award-winning cocoa-flavored pediatric cough remedy.

“Many cough treatments have deficiencies in their efficacy, safety and compliance profiles and Infirst Healthcare is committed to finding solutions that address these issues," Manfred Scheske, Infirst CEO said. "Introducing compliance optimized pediatric products that taste better to children is a step in this direction. We are excited about the start of our U.S. operations in the pediatric OTC market.

Dr. Cocoa was named "Best Product" at the 2013 US Cough & Cold ECRM conference, an award sponsored by DSN. The patent protected line of products has been formulated with real chocolate in order to improve compliance for better symptom relief. 

The Dr. Cocoa brand is brought to life through the Dr. Cocoa Owl character which depicts the family doctor speaking to children and parents in a knowledgeable and credible way, and will be used throughout all marketing and communications activity, the company noted. 

With this agreement, Infirst Healthcare now holds the exclusive global rights for the use of cocoa and chocolate in cough products. Infirst Healthcare will be building its U.S. presence and preparing for the launch of Dr. Cocoa in 2014. Infirst Healthcare will be represented in the U.S. by Advantage Consumer Healthcare.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Inergetics partners with the Podiatree Co. on new nerve health support supplement

BY Michael Johnsen

NEWARK, N.J. — Inergetics and the Podiatree Co. on Tuesday launched Intrinsix, a podiatry-exclusive nerve health support supplement enriched with calcium and vitamin D.

Developed alongside pharmacist, Robert Graci, Inergetics has created a unique formula to support healthy nerve function and specifically help diabetic patients who experience nerve-related symptoms in their extremities, which include tingling, pain, burning and loss of sensation, the company stated. 

"With approximately 15,000 podiatrists practicing in the U.S., we are taking a direct sales approach to help them support the ever-increasing proportion of the population suffering with diabetes," Inergetics CEO Mike James said. "Intrinsix is a great addition to the Inergetics family and we look forward to continuing our work with The Podiatree Company to advance foot care for the benefit of patients."

"As a company dedicated to the podiatry specialty market, we take pride in being able to provide our physician partners with unique and efficacious specialty products to meet their patients’ needs," Graci said.

Intrinsix contains a unique blend of alpha lipoic acid, benfotiamine, calcium and vitamins B6, B12 and D. The formula is safe for patients with strict dietary restrictions, including vegetarians and those with sugar-free, sodium-free and starch-free diets, Inergetics noted.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?